Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) Trial

• Published in: JNCI : Journal of the National Cancer Institute Vol. 110; no. 6; pp. 616 - 627
• Main Authors: Roseweir, Antonia K, Bennett, Lindsay, Dickson, Ashley, Cheng, Kelvin, Quintayo, Mary-Anne, Bayani, Jane, McMillan, Donald C, Horgan, Paul G, van de Velde, Cornelis J H, Seynaeve, Caroline, Hasenburg, Annette, Kieback, Dirk G, Markopoulos, Christos, Dirix, Luc Y, Rea, Daniel W, Mallon, Elizabeth A, Bartlett, John M S, Edwards, Joanne
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01.06.2018

Abstract Background Aromatase inhibitors improve disease-free survival compared with tamoxifen in postmenopausal women with hormone receptor–positive breast cancer. The Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial compared exemestane monotherapy with sequential therapy of tamoxifen f...